International Journal of Cell Biology
Volume 2012 (2012), Article ID 908724, 9 pages
http://dx.doi.org/10.1155/2012/908724
Review Article
Altered Gene Expression, Mitochondrial Damage and Oxidative Stress: Converging Routes in Motor Neuron Degeneration
1Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 00133 Rome, Italy
2Institute for Cell Biology and Neurobiology, CNR, 00100 Rome, Italy
3IRCCS Fondazione Santa Lucia, 00143 Rome, Italy
Received 13 February 2012; Accepted 15 March 2012
Academic Editor: Giuseppe Filomeni
Copyright © 2012 Luisa Rossi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- S. Saxena and P. Caroni, “Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration,” Neuron, vol. 71, no. 1, pp. 35–48, 2011. View at Publisher · View at Google Scholar · View at Scopus
- M. J. Strong and P. H. Gordon, “Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum?” Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 6, no. 1, pp. 8–16, 2005. View at Publisher · View at Google Scholar · View at Scopus
- H. O. Nousiainen, M. Kestilä, N. Pakkasjärvi et al., “Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease,” Nature Genetics, vol. 40, no. 2, pp. 155–157, 2008. View at Publisher · View at Google Scholar · View at Scopus
- M. R. Lunn and C. H. Wang, “Spinal muscular atrophy,” The Lancet, vol. 371, no. 9630, pp. 2120–2133, 2008. View at Publisher · View at Google Scholar · View at Scopus
- G. Sobue, Y. Hashizume, E. Mukai, M. Hirayama, T. Mitsuma, and A. Takahashi, “X-linked recessive bulbospinal neuronopathy. A clinicopathological study,” Brain, vol. 112, part 1, pp. 209–232, 1989. View at Google Scholar · View at Scopus
- A. R. La Spada, E. M. Wilson, D. B. Lubahn, A. E. Harding, and K. H. Fischbeck, “Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy,” Nature, vol. 352, no. 6330, pp. 77–79, 1991. View at Publisher · View at Google Scholar · View at Scopus
- A. D. Sperfeld, J. Karitzky, D. Brummer et al., “X-linked bulbospinal neuronopathy: Kennedy disease,” Archives of Neurology, vol. 59, no. 12, pp. 1921–1926, 2002. View at Publisher · View at Google Scholar · View at Scopus
- B. Udd, V. Juvonen, L. Hakamies et al., “High prevalence of Kennedy's disease Western Finland—is the syndrome underdiagnosed?” Acta Neurologica Scandinavica, vol. 98, no. 2, pp. 128–133, 1998. View at Google Scholar · View at Scopus
- P. N. Valdmanis, H. Daoud, P. A. Dion, and G. A. Rouleau, “Recent advances in the genetics of amyotrophic lateral sclerosis,” Current Neurology and Neuroscience Reports, vol. 9, no. 3, pp. 198–205, 2009. View at Publisher · View at Google Scholar · View at Scopus
- P. A. Cox and O. W. Sacks, “Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam,” Neurology, vol. 58, no. 6, pp. 956–959, 2002. View at Google Scholar · View at Scopus
- B. A. Golomb, E. K. Kwon, S. Koperski, and M. A. Evans, “Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) statin effects study,” Drug Safety, vol. 32, no. 8, pp. 649–661, 2009. View at Publisher · View at Google Scholar · View at Scopus
- C. A. Harwood, C. J. McDermott, and P. J. Shaw, “Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence,” Amyotrophic Lateral Sclerosis, vol. 10, no. 4, pp. 191–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
- A. Chiò, G. Benzi, M. Dossena, R. Mutani, and G. Mora, “Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players,” Brain, vol. 128, part 3, pp. 472–476, 2005. View at Publisher · View at Google Scholar · View at Scopus
- P. Wicks, J. Ganesalingham, C. Collin, M. Prevett, N. P. Leigh, and A. Al-Chalabi, “Three soccer playing friends with simultaneous amyotrophic lateral sclerosis,” Amyotrophic Lateral Sclerosis, vol. 8, no. 3, pp. 177–179, 2007. View at Publisher · View at Google Scholar · View at Scopus
- E. J. Kasarskis, J. H. Lindquist, C. J. Coffman et al., “Clinical aspects of ALS in Gulf War Veterans,” Amyotrophic Lateral Sclerosis, vol. 10, no. 1, pp. 35–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
- N. Vanacore, P. Cocco, D. Fadda, and M. Dosemeci, “Job strain, hypoxia and risk of amyotrophic lateral sclerosis: results from a death certificate study,” Amyotrophic Lateral Sclerosis, vol. 11, no. 5, pp. 430–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
- H. Chen, M. Richard, D. P. Sandler, D. M. Umbach, and F. Kamel, “Head injury and amyotrophic lateral sclerosis,” American Journal of Epidemiology, vol. 166, no. 7, pp. 810–816, 2007. View at Publisher · View at Google Scholar · View at Scopus
- S. Schmidt, L. C. Kwee, K. D. Allen, and E. Z. Oddone, “Association of ALS with head injury, cigarette smoking and APOE genotypes,” Journal of the Neurological Sciences, vol. 291, no. 1-2, pp. 22–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
- A. C. McKee et al., “TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy,” Journal of Neuropathology and Experimental Neurology, vol. 69, no. 9, pp. 918–929, 2010. View at Google Scholar
- V. Gallo, H. B. Bueno-De-Mesquita, R. Vermeulen et al., “Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort,” Annals of Neurology, vol. 65, no. 4, pp. 378–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
- F. Kamel, D. M. Umbach, H. Hu et al., “Lead exposure as a risk factor for amyotrophic lateral sclerosis,” Neurodegenerative Diseases, vol. 2, no. 3-4, pp. 195–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
- B. R. Brooks, “Risk factors in the early diagnosis of ALS: North American epidemiological studies,” Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 1, supplement 1, pp. S19–S26, 2000. View at Google Scholar
- C. J. Burns, K. K. Beard, and J. B. Cartmill, “Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945-94: an update,” Occupational and Environmental Medicine, vol. 58, no. 1, pp. 24–30, 2001. View at Publisher · View at Google Scholar · View at Scopus
- N. A. Sutedja, J. H. Veldink, K. Fischer et al., “Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review,” Amyotrophic Lateral Sclerosis, vol. 10, no. 5-6, pp. 302–309, 2009. View at Publisher · View at Google Scholar · View at Scopus
- M. Cozzolino and M. T. Carri, “Mitochondrial dysfunction in ALS,” Progress in Neurobiology, vol. 97, no. 2, pp. 54–66, 2012. View at Google Scholar
- M. Hayashi, S. Araki, N. Arai et al., “Oxidative stress and disturbed glutamate transport in spinal muscular atrophy,” Brain and Development, vol. 24, no. 8, pp. 770–775, 2002. View at Publisher · View at Google Scholar · View at Scopus
- L. Wan, E. Ottinger, S. Cho, and G. Dreyfuss, “Inactivation of the SMN complex by oxidative stress,” Molecular Cell, vol. 31, no. 2, pp. 244–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
- E. A. Schon and S. Przedborski, “Mitochondria: the next (Neurode) generation,” Neuron, vol. 70, no. 6, pp. 1033–1053, 2011. View at Publisher · View at Google Scholar · View at Scopus
- A. Berger, J. A. Mayr, D. Meierhofer et al., “Severe depletion of mitochondrial DNA in spinal muscular atrophy,” Acta Neuropathologica, vol. 105, no. 3, pp. 245–251, 2003. View at Google Scholar · View at Scopus
- S. Jongpiputvanich, T. Sueblinvong, and T. Norapucsunton, “Mitochondrial respiratory chain dysfunction in various neuromuscular diseases,” Journal of Clinical Neuroscience, vol. 12, no. 4, pp. 426–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
- G. Acsadi, I. Lee, X. Li et al., “Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy,” Journal of Neuroscience Research, vol. 87, no. 12, pp. 2748–2756, 2009. View at Publisher · View at Google Scholar · View at Scopus
- T. Voigt, K. Meyer, O. Baum, and D. Schümperli, “Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing,” Neuromuscular Disorders, vol. 20, no. 11, pp. 744–752, 2010. View at Publisher · View at Google Scholar · View at Scopus
- S. Ranganathan, G. G. Harmison, K. Meyertholen, M. Pennuto, B. G. Burnett, and K. H. Fischbeck, “Mitochondrial abnormalities in spinal and bulbar muscular atrophy,” Human Molecular Genetics, vol. 18, no. 1, pp. 27–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
- A. M. J. Beauchemin, B. Gottlieb, L. K. Beitel, Y. A. Elhaji, L. Pinsky, and M. A. Trifiro, “Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy,” Brain Research Bulletin, vol. 56, no. 3-4, pp. 285–297, 2001. View at Publisher · View at Google Scholar · View at Scopus
- A. Malaspina, N. Kaushik, and J. de Belleroche, “Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays,” Journal of Neurochemistry, vol. 77, no. 1, pp. 132–145, 2001. View at Publisher · View at Google Scholar · View at Scopus
- C. W. Lederer, A. Torrisi, M. Pantelidou, N. Santama, and S. Cavallaro, “Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis,” BMC Genomics, vol. 8, article 26, 2007. View at Publisher · View at Google Scholar · View at Scopus
- F. Tanaka et al., “Neuropathology and omics in motor neuron diseases,” Neuropathology. In press. View at Publisher · View at Google Scholar
- M. R. Vargas, M. Pehar, P. J. Díaz-Amarilla, J. S. Beckman, and L. Barbeito, “Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1,” Journal of Neuroscience Research, vol. 86, no. 16, pp. 3515–3525, 2008. View at Publisher · View at Google Scholar · View at Scopus
- J. L. Gonzalez de Aguilar, C. Niederhauser-Wiederkehr, B. Halter et al., “Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model,” Physiological Genomics, vol. 32, no. 2, pp. 207–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
- P. F. Pradat et al., “Muscle gene expression is a marker of amyotrophic lateral sclerosis severity,” Neuro-Degenerative Diseases, vol. 9, no. 1, pp. 38–52, 2012. View at Google Scholar
- C. Y. Wu, D. Whye, L. Glazewski et al., “Proteomic assessment of a cell model of spinal muscular atrophy,” BMC Neuroscience, vol. 12, article 25, 2011. View at Publisher · View at Google Scholar · View at Scopus
- R. N. Saha and K. Pahan, “HATs and HDACs in neurodegeneration: A tale of disconcerted acetylation homeostasis,” Cell Death and Differentiation, vol. 13, no. 4, pp. 539–550, 2006. View at Publisher · View at Google Scholar · View at Scopus
- S. Petri, M. Kiaei, K. Kipiani et al., “Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis,” Neurobiology of Disease, vol. 22, no. 1, pp. 40–49, 2006. View at Publisher · View at Google Scholar · View at Scopus
- M. E. Cudkowicz, P. L. Andres, S. A. Macdonald et al., “Phase 2 study of sodium phenylbutyrate in ALS,” Amyotrophic Lateral Sclerosis, vol. 10, no. 2, pp. 99–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
- F. Sugai, Y. Yamamoto, K. Miyaguchi et al., “Benefit of valproic acid in suppressing disease progression of ALS model mice,” European Journal of Neuroscience, vol. 20, no. 11, pp. 3179–3183, 2004. View at Publisher · View at Google Scholar · View at Scopus
- H. L. Feng, Y. Leng, C. H. Ma, J. Zhang, M. Ren, and D. M. Chuang, “Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model,” Neuroscience, vol. 155, no. 3, pp. 567–572, 2008. View at Publisher · View at Google Scholar · View at Scopus
- Y. E. Yoo and C. P. Ko, “Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis,” Experimental Neurology, vol. 231, no. 1, pp. 147–159, 2011. View at Publisher · View at Google Scholar · View at Scopus
- S. H. Kim, N. P. Shanware, M. J. Bowler, and R. S. Tibbetts, “Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA,” The Journal of Biological Chemistry, vol. 285, no. 44, pp. 34097–34105, 2010. View at Publisher · View at Google Scholar · View at Scopus
- L. E. Kernochan, M. L. Russo, N. S. Woodling et al., “The role of histone acetylation in SMN gene expression,” Human Molecular Genetics, vol. 14, no. 9, pp. 1171–1182, 2005. View at Publisher · View at Google Scholar · View at Scopus
- E. Hahnen, I. Y. Eyüpoglu, L. Brichta et al., “In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy,” Journal of Neurochemistry, vol. 98, no. 1, pp. 193–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
- A. M. Avila, B. G. Burnett, A. A. Taye et al., “Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 659–671, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. Riessland, L. Brichta, E. Hahnen, and B. Wirth, “The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells,” Human Genetics, vol. 120, no. 1, pp. 101–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
- K. Rak, B. D. Lechner, C. Schneider, H. Drexl, M. Sendtner, and S. Jablonka, “Valproic acid blocks excitability in SMA type I mouse motor neurons,” Neurobiology of Disease, vol. 36, no. 3, pp. 477–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
- H. R. Fuller, N. T. Man, L. T. Lam, V. A. Shamanin, E. J. Androphy, and G. E. Morris, “Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells,” Journal of Proteome Research, vol. 9, no. 8, pp. 4228–4233, 2010. View at Publisher · View at Google Scholar · View at Scopus
- M. C. Evans, J. J. Cherry, E. J. Androphy et al., “Differential regulation of the SMN2 gene by individual HDAC proteins,” Biochemical and Biophysical Research Communications, vol. 414, no. 1, pp. 25–30, 2011. View at Google Scholar
- M. Minamiyama, M. Katsuno, H. Adachi et al., “Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy,” Human Molecular Genetics, vol. 13, no. 11, pp. 1183–1192, 2004. View at Publisher · View at Google Scholar · View at Scopus
- S. L. Berger, “The complex language of chromatin regulation during transcription,” Nature, vol. 447, no. 7143, pp. 407–412, 2007. View at Publisher · View at Google Scholar · View at Scopus
- O. Tapia, R. Bengoechea, M. T. Berciano, and M. Lafarga, “Nucleolar targeting of coilin is regulated by its hypomethylation state,” Chromosoma, vol. 119, no. 5, pp. 527–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
- K. Tripsianes, “Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins,” Nature Structural & Molecular Biology, vol. 18, no. 12, pp. 1414–1420, 2011. View at Google Scholar
- G. B. Gonsalvez, L. Tian, J. K. Ospina, F. M. Boisvert, A. I. Lamond, and A. G. Matera, “Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins,” Journal of Cell Biology, vol. 178, no. 5, pp. 733–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
- J. Hauke, M. Riessland, S. Lunke et al., “Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition,” Human Molecular Genetics, vol. 18, no. 2, pp. 304–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
- D. Bäumer, O. Ansorge, M. Almeida, and K. Talbot, “The role of RNA processing in the pathogenesis of motor neuron degeneration,” Expert Reviews in Molecular Medicine, vol. 12, p. e21, 2010. View at Publisher · View at Google Scholar · View at Scopus
- P. Corcia, W. Camu, J. Praline, P. H. Gordon, P. Vourch, and C. Andres, “The importance of the SMN genes in the genetics of sporadic ALS,” Amyotrophic Lateral Sclerosis, vol. 10, no. 5-6, pp. 436–440, 2009. View at Publisher · View at Google Scholar · View at Scopus
- Y. Piao, T. Hashimoto, S. Takahama et al., “Survival motor neuron (SMN) protein in the spinal anterior horn cells of patients with sporadic amyotrophic lateral sclerosis,” Brain Research, vol. 1372, pp. 152–159, 2011. View at Publisher · View at Google Scholar · View at Scopus
- M. Dejesus-Hernandez et al., “Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS,” Neuron, vol. 72, no. 2, pp. 245–256, 2011. View at Google Scholar
- A. E. Renton et al., “A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD,” Neuron, vol. 72, no. 2, pp. 257–268, 2011. View at Google Scholar
- M. Wojciechowska and W. J. Krzyzosiak, “Cellular toxicity of expanded RNA repeats: focus on RNA foci,” Human Molecular Genetics, vol. 20, no. 19, pp. 3811–3821, 2011. View at Google Scholar
- G. Sicot, G. Gourdon, and M. Gomes-Pereira, “Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges,” Human Molecular Genetics, vol. 20, no. 2, pp. R116–R123, 2011. View at Google Scholar
- E. Buratti, A. Brindisi, M. Giombi, S. Tisminetzky, Y. M. Ayala, and F. E. Baralle, “TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing,” The Journal of Biological Chemistry, vol. 280, no. 45, pp. 37572–37584, 2005. View at Publisher · View at Google Scholar · View at Scopus
- O. A. Sofola, P. Jin, Y. Qin et al., “RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a drosophila model of FXTAS,” Neuron, vol. 55, no. 4, pp. 565–571, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. J. Hitchler and F. E. Domann, “An epigenetic perspective on the free radical theory of development,” Free Radical Biology and Medicine, vol. 43, no. 7, pp. 1023–1036, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. J. Hitchler and F. E. Domann, “Metabolic defects provide a spark for the epigenetic switch in cancer,” Free Radical Biology and Medicine, vol. 47, no. 2, pp. 115–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
- B. Langley, M. A. D'Annibale, K. Suh et al., “Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21waf1/cip1 in cell cycle-independent neuroprotection,” Journal of Neuroscience, vol. 28, no. 1, pp. 163–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
- K. Doyle and F. A. Fitzpatrick, “Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function,” The Journal of Biological Chemistry, vol. 285, no. 23, pp. 17417–17424, 2010. View at Publisher · View at Google Scholar · View at Scopus
- J. Hnilicová, S. Hozeifi, E. Dušková, J. Icha, T. Tománková, and D. Staněk, “Histone deacetylase activity modulates alternative splicing,” PLoS ONE, vol. 6, no. 2, 2011. View at Publisher · View at Google Scholar · View at Scopus
- I. Rahman, J. Marwick, and P. Kirkham, “Redox modulation of chromatin remodeling: Impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression,” Biochemical Pharmacology, vol. 68, no. 6, pp. 1255–1267, 2004. View at Publisher · View at Google Scholar · View at Scopus
- Q. Li, C. V. Velde, A. Israelson et al., “ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 49, pp. 21146–21151, 2010. View at Publisher · View at Google Scholar · View at Scopus
- D. Bergemalm, K. Forsberg, P. Andreas Jonsson et al., “Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis,” Molecular and Cellular Proteomics, vol. 8, no. 6, pp. 1306–1317, 2009. View at Publisher · View at Google Scholar · View at Scopus
- T. Massignan, F. Casoni, M. Basso et al., “Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse,” Biochemical and Biophysical Research Communications, vol. 353, no. 3, pp. 719–725, 2007. View at Publisher · View at Google Scholar · View at Scopus
- A. Maracchioni, A. Totaro, D. F. Angelini et al., “Mitochondrial damage modulates alternative splicing in neuronal cells: Implications for neurodegeneration,” Journal of Neurochemistry, vol. 100, no. 1, pp. 142–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
- S. C. Lenzken, V. Romeo, F. Zolezzi et al., “Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration,” Human Mutation, vol. 32, no. 2, pp. 168–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
- A. Brunet, L. B. Sweeney, J. F. Sturgill et al., “Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase,” Science, vol. 303, no. 5666, pp. 2011–2015, 2004. View at Publisher · View at Google Scholar · View at Scopus
- Z. Lu, X. Xu, X. Hu et al., “PGC-1α regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload,” Antioxidants and Redox Signaling, vol. 13, no. 7, pp. 1011–1022, 2010. View at Publisher · View at Google Scholar · View at Scopus
- K. Aquilano, P. Vigilanza, S. Baldelli, B. Pagliei, G. Rotilio, and M. R. Ciriolo, “Peroxisome proliferator-activated receptor γ co-activator 1 α (PGC-1α) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis,” The Journal of Biological Chemistry, vol. 285, no. 28, pp. 21590–21599, 2010. View at Publisher · View at Google Scholar · View at Scopus
- J. H. Lim, Y. M. Lee, Y. S. Chun, J. Chen, J. E. Kim, and J. W. Park, “Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha.,” Molecular cell, vol. 38, no. 6, pp. 864–878, 2010. View at Google Scholar · View at Scopus
- E. M. Dioum, R. Chen, M. S. Alexander et al., “Regulation of hypoxia-inducible factor 2α signaling by the stress-responsive deacetylase sirtuin 1,” Science, vol. 324, no. 5932, pp. 1289–1293, 2009. View at Publisher · View at Google Scholar · View at Scopus
- I. Mattagajasingh, C. S. Kim, A. Naqvi et al., “SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 37, pp. 14855–14860, 2007. View at Publisher · View at Google Scholar · View at Scopus
- Y. Yang, W. Fu, J. Chen et al., “SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress,” Nature Cell Biology, vol. 9, no. 11, pp. 1253–1262, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. K. Han, E. K. Song, Y. Guo, X. Ou, C. Mantel, and H. E. Broxmeyer, “SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization,” Cell Stem Cell, vol. 2, no. 3, pp. 241–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
- F. Wang, M. Nguyen, F. X. F. Qin, and Q. Tong, “SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction,” Aging Cell, vol. 6, no. 4, pp. 505–514, 2007. View at Publisher · View at Google Scholar · View at Scopus
- E. L. Bell, B. M. Emerling, S. J. H. Ricoult, and L. Guarente, “SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production,” Oncogene, vol. 30, no. 26, pp. 2986–2996, 2011. View at Publisher · View at Google Scholar · View at Scopus
- R. Tao, M. C. Coleman, J. D. Pennington et al., “Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress,” Molecular Cell, vol. 40, no. 6, pp. 893–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
- Y. Chen, J. Zhang, Y. Lin et al., “Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS,” EMBO Reports, vol. 12, no. 6, pp. 534–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
- W. C. Hallows, W. Yu, B. C. Smith et al., “Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction,” Molecular Cell, vol. 41, no. 2, pp. 139–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
- B. H. Ahn, H. S. Kim, S. Song et al., “A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14447–14452, 2008. View at Publisher · View at Google Scholar · View at Scopus
- D. B. Lombard, F. W. Alt, H. L. Cheng et al., “Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation,” Molecular and Cellular Biology, vol. 27, no. 24, pp. 8807–8814, 2007. View at Publisher · View at Google Scholar · View at Scopus
- S. Someya, W. Yu, W. C. Hallows et al., “Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction,” Cell, vol. 143, no. 5, pp. 802–812, 2010. View at Publisher · View at Google Scholar · View at Scopus
- M. C. Haigis, R. Mostoslavsky, K. M. Haigis et al., “SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic β cells,” Cell, vol. 126, no. 5, pp. 941–954, 2006. View at Publisher · View at Google Scholar · View at Scopus
- T. Nakagawa, D. J. Lomb, M. C. Haigis, and L. Guarente, “SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle,” Cell, vol. 137, no. 3, pp. 560–570, 2009. View at Publisher · View at Google Scholar · View at Scopus
- L. Zhong, A. D'Urso, D. Toiber et al., “The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α,” Cell, vol. 140, no. 2, pp. 280–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
- O. Vakhrusheva, C. Smolka, P. Gajawada et al., “Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice,” Circulation Research, vol. 102, no. 6, pp. 703–710, 2008. View at Publisher · View at Google Scholar · View at Scopus
- L. G. Bilsland, E. Sahai, G. Kelly, M. Golding, L. Greensmith, and G. Schiavo, “Deficits in axonal transport precede ALS symptoms in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 47, pp. 20523–20528, 2010. View at Publisher · View at Google Scholar · View at Scopus